Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Beta-carbonic anhydrase | 0.0948 | 0.5761 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1011 | 0.6263 | 0.5788 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1477 | 1 | 0.5 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.1011 | 0.6263 | 0.5788 |
Mycobacterium tuberculosis | Probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase) | 0.0759 | 0.4239 | 0.7358 |
Trichomonas vaginalis | conserved hypothetical protein | 0.1477 | 1 | 0.5 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1011 | 0.6263 | 0.5 |
Echinococcus multilocularis | carbonic anhydrase II | 0.1011 | 0.6263 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1037 | 0.6473 | 1 |
Trypanosoma cruzi | carbonic anhydrase-like protein, putative | 0.1011 | 0.6263 | 0.5 |
Schistosoma mansoni | carbonic anhydrase | 0.1411 | 0.9475 | 1 |
Trypanosoma brucei | carbonic anhydrase-like protein | 0.1011 | 0.6263 | 0.5 |
Leishmania major | carbonic anhydrase family protein, putative | 0.1411 | 0.9475 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.1011 | 0.6263 | 1 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.1011 | 0.6263 | 0.9545 |
Toxoplasma gondii | hypothetical protein | 0.0461 | 0.1849 | 0.5 |
Entamoeba histolytica | carbonic anhydrase, putative | 0.1411 | 0.9475 | 0.5 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.1011 | 0.6263 | 1 |
Plasmodium falciparum | carbonic anhydrase | 0.0461 | 0.1849 | 0.5 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.1011 | 0.6263 | 0.9545 |
Mycobacterium tuberculosis | Beta-carbonic anhydrase CanB | 0.0883 | 0.5237 | 0.9089 |
Echinococcus granulosus | carbonic anhydrase II | 0.1011 | 0.6263 | 1 |
Mycobacterium leprae | CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) | 0.1411 | 0.9475 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.